Abstract
Hyponatremia represents an independent risk factor for osteoporosis and fractures, affecting both bone density and quality. A direct stimulation of bone resorption in the presence of reduced extracellular sodium concentrations ([Na+]) has been shown, but the effects of low [Na+] on osteoblasts have not been elucidated. We investigated the effects of a chronic reduction of extracellular [Na+], independently of osmotic stress, on human mesenchymal stromal cells (hMSC) from bone marrow, the common progenitor for osteoblasts and adipocytes. hMSC adhesion and viability were significantly inhibited by reduced [Na+], but their surface antigen profile and immuno-modulatory properties were not altered. In low [Na+], hMSC were able to commit toward both the osteogenic and the adipogenic phenotypes, as demonstrated by differentiation markers analysis. However, the dose-dependent increase in the number of adipocytes as a function of reduced [Na+] suggested a preferential commitment toward the adipogenic phenotype at the expense of osteogenesis. The amplified inhibitory effect on the expression of osteoblastic markers exerted by adipocytes-derived conditioned media in low [Na+] further supported this observation. The analysis of cytoskeleton showed that low [Na+] were associated with disruption of tubulin organization in hMSC-derived osteoblasts, thus suggesting a negative effect on bone quality. Finally, hMSC-derived osteoblasts increased their expression of factors stimulating osteoclast recruitment and activity. These findings confirm that hyponatremia should be carefully taken into account because of its negative effects on bone, in addition to the known neurological effects, and indicate for the first time that impaired osteogenesis may be involved.
Similar content being viewed by others
References
A. Upadhyay, B.L. Jaber, N.E. Madias, Incidence and prevalence of hyponatremia. Am. J. Med. 119, S30–S35 (2006)
E.J. Hoorn, J. Lindemans, R. Zietse, Development of severe hyponatremia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrol. Dial. Transplant. 21, 70–76 (2006)
G. Corona, C. Giuliani, G. Parenti, D. Norello, J.G. Verbalis, G. Forti, M. Maggi, A. Peri, Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis. PLoS One 8, e80451 (2013)
B. Renneboog, W. Musch, X. Vandemergel, M.U. Manto, G. Decaux, Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am. J. Med. 119, 71.e1–71.e8 (2006)
S. Kinsella, S. Moran, M.O. Sullivan, M.G. Molloy, J.A. Eustace, Hyponatremia independent of osteoporosis is associated with fracture occurrence. Clin. J. Am. Soc. Nephrol. 5, 275–280 (2010)
E.J. Hoorn, F. Rivadeneira, J.B. van Meurs, G. Ziere, B.H. Stricker, A. Hofman, H.A. Pols, R. Zietse, A.G. Uitterlinden, M.C. Zillikens, Mild hyponatremia as a risk factor for fractures: the Rotterdam Study. J. Bone Miner. Res. 26, 1822–1828 (2011)
R. Hasserius, M.K. Karlsson, B.E. Nilsson, I. Redlund-Johnell, O. Johnell, Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study. Osteoporosis Int. 14, 61–68 (2003)
F. Gankam-Kengne, C. Andres, L. Sattar, C. Melot, G. Decaux, Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM 101, 583–588 (2008)
H.S. Sandhu, E. Gilles, M.V. DeVita, G. Panagopoulos, M.F. Michelis, Hyponatremia associated with large-bone fracture in elderly patients. Int. Urol. Nephrol. 41, 733–737 (2009)
R. Tolouian, T. Alhamad, M. Farazmand, Z.D. Mulla, The correlation of hip fracture and hyponatremia in the elderly. J. Nephrol. 25, 789–793 (2012)
T. Hagino, S. Ochiai, Y. Watanabe, S. Senga, M. Saito, Y. Takayama, M. Wako, T. Ando, E. Sato, H. Haro, Hyponatremia at admission is associated with in-hospital death in patients with hip fracture. Arch. Orthop. Trauma Surg. 133, 507–511 (2013)
J.G. Verbalis, J. Barsony, Y. Sugimura, Y. Tian, D.J. Adams, E.A. Carter, H.E. Resnick, Hyponatremia-induced osteoporosis. J. Bone Miner. Res. 25, 554–563 (2010)
A.S. Sejling, U. Pedersen-Bjergaard, P. Eiken, Syndrome of inappropriate ADH secretion and severe osteoporosis. J. Clin. Endocrinol. Metab. 97, 4306–4310 (2012)
A.S. Sejling, A.L. Thorsteinsson, U. Pedersen-Bjergaard, P. Eiken, Recovery from SIADH-associated osteoporosis: a case report. J. Clin. Endocrinol. Metab. 99, 3527–3530 (2014)
C. Kruse, P. Eiken, P. Vestergaard, Hyponatremia and osteoporosis: insights from the Danish National Patient Registry. Osteoporos. Int. 26, 1005–1016 (2015)
F. Afshinnia, B. Sundaram, R.J. Ackermann, K.K. Wong, Hyponatremia and osteoporosis: reappraisal of a novel association. Osteoporos. Int. (2015). doi:10.1007/s00198-015-3108-z
J. Barsony, Y. Sugimura, J.G. Verbalis, Osteoclast response to low extracellular sodium and the mechanism of hyponatremia-induced bone loss. J. Biol. Chem. 286, 10864–10875 (2011)
W.H. Bergstrom, The participation of bone in total body sodium metabolism in the rat. J. Clin. Invest. 34, 97–104 (1955)
I.S. Edelman, A.H. James, H. Baden, F.D. Moore, Electrolyte composition of bone and the penetration of radiosodium and deuterium oxide into dog and human bone. J. Clin. Invest. 33, 122–131 (1954)
J.G. Verbalis, S.R. Goldsmith, A. Greenberg, C. Korzelius, R.W. Schrier, R.H. Sterns, C.J. Thompson, Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am. J. Med. 126, S1–S42 (2013)
S. Benvenuti, C. Deledda, P. Luciani, G. Modi, A. Bossio, C. Giuliani, B. Fibbi, A. Peri, Low extracellular sodium causes neuronal distress independently of reduced osmolality in an experimental model of chronic hyponatremia. Neuromolecular Med. 15, 493–503 (2013)
D. Baksh, L. Song, R.S. Tuan, Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J. Cell Mol. Med. 8, 301–316 (2004)
P. Sambrook, C. Cooper, Osteoporosis. Lancet 367, 2010–2018 (2006)
R. Tamma, L. Sun, C. Cuscito, P. Lu, M. Corcelli, J. Li, G. Colaianni, S.S. Moonga, A. Di Benedetto, M. Grano, S. Colucci, T. Yuen, M.I. New, A. Zallone, M. Zaidi, Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia. Proc. Natl. Acad. Sci. USA 110, 18644–18649 (2013)
T.J. Wronski, C.C. Walsh, L.A. Ignaszewski, Histologic evidence for osteopenia and increased bone turnover in ovariectomized rats. Bone 7, 119–123 (1986)
E.J. Moerman, K. Teng, D.A. Lipschitz, B. Lecka-Czernik, Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPARγ2 transcription factor and TGF-β/BMP signalling pathways. Aging Cell 3, 379–389 (2004)
M. Zayzafon, W.E. Gathings, J.M. McDonald, Modeled microgravity inhibit osteogenic differentiation of human mesenchymal stem cells and increases adipogenesis. Endocrinology 145, 2421–2432 (2004)
L. Forsen, H.E. Meyer, K. Misthjell, T.H. Edna, Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trondelag Health Survey. Diabetologia 42, 920–925 (1999)
S. Benvenuti, I. Cellai, P. Luciani, C. Deledda, S. Baglioni, C. Giuliani, R. Saccaridi, B. Mozzanti, S. Dal Pozzo, E. Mannucci, A. Peri, M. Serio, Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells. J. Endocrinol. Invest. 30, RC26–RC30 (2007)
M.F. Pittenger, A.M. Mackay, S.C. Beck, R.K. Jaiswal, R. Douglas, J.D. Mosca, M.A. Moorman, D.W. Simonetti, S. Craig, D.R. Marshak, Multilineage potential of adult human mesenchymal stem cells. Science 284, 143–147 (1999)
A.C. Maurin, P.M. Chavassieux, L. Frappart, P.D. Delmas, C.M. Serre, P.J. Meunier, Influence of mature adipocytes on osteoblast proliferation in human primary co-cultures. Bone 26, 485–489 (2000)
A.C. Maurin, P.M. Chavassieux, E. Vericel, P.J. Meunier, Role of polyunsaturated fatty acids in the inhibitory effect of human adipocytes on osteoblastic proliferation. Bone 31, 260–266 (2002)
J. Bassols, F.J. Ortega, J.M. Moreno-Navarrete, B. Peral, W. Ricart, J.M. Fernández-Real, Study of the proinflammatory role of human differentiated omental adipocytes. J. Cell. Biochem. 107, 1107–1117 (2009)
S. Kwan Tat, M. Padrines, S. Théoleyre, D. Heymann, Y. Fortun, IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 15, 49–60 (2004)
C.J. Rosen, C. Ackert-Bicknell, J.P. Rodriguez, A.M. Pino, Marrow fat and the bone microenvironment: developmental, functional and pathological implications. Crit. Rev. Eukariot. Gene Expr. 19, 109–124 (2009)
A. Krings, S. Rahman, S. Huang, Y. Lu, P.J. Czernik, B. Lecka-Czernik, Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes. Bone 50, 546–552 (2012)
M. Zhao, S. Ko, J.H. Liu, D. Chen, J. Zhang, B. Wang, S.E. Harris, B.O. Oyajobi, G.R. Mundy, Inhibition of microtubule assembly in osteoblasts stimulates bone morphogenetic protein 2 expression and bone formation through transcription factor Gli2. Mol. Cell. Biol. 29, 1291–1305 (2009)
H.F. Al-Jallad, V.D. Myneni, S.A. Piercy-Kotb, N. Chabot, A. Mulani, J.W. Keillor, M.T. Kaartinen, Plasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamics. PLoS One 6, e15893 (2011)
W. Yang, X. Guo, S. Thein, F. Xu, S. Sugii, P.W. Baas, G.K. Radda, W. Han, Regulation of adipogenesis by cytoskeleton remodeling is facilitated by acetyltransferase MEC-17-dependent acetylation of α-tubulin. Biochem. J. 449, 605–612 (2013)
A.P. Molloy, F.T. Martin, R.M. Dwyer, T.P. Griffin, M. Murphy, F.P. Barry, T. O’Brien, M.J. Kerin, Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells. Int. J. Cancer 124, 326–332 (2009)
A. Kortesidis, A. Zannettino, S. Isenmann, S. Shi, T. Lapidot, S. Gronthos, Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 105, 3793–3801 (2005)
H. Goto, A. Hozumi, M. Osaki, T. Fukushima, K. Sakamoto, A. Yonekura, M. Tomita, K. Furukawa, H. Shindo, H. Baba, Primary human bone marrow adipocytes support TNF-α-induced osteoclast differentiation and function through RANKL expression. Cytokine 56, 662–668 (2011)
Acknowledgments
The authors wish to thank Ente Cassa di Risparmio di Firenze for supporting the study.
Conflict of interest
Benedetta Fibbi, Susanna Benvenuti, Corinna Giuliani, Cristiana Deledda, Paola Luciani, Monica Monici, Benedetta Mazzanti, Clara Ballerini, and Alessandro Peri declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Fibbi, B., Benvenuti, S., Giuliani, C. et al. Low extracellular sodium promotes adipogenic commitment of human mesenchymal stromal cells: a novel mechanism for chronic hyponatremia-induced bone loss. Endocrine 52, 73–85 (2016). https://doi.org/10.1007/s12020-015-0663-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-015-0663-1